The global ophthalmic devices market is expected to grow at a CAGR of 5.7% in the first half of the forecast period. The market is expected to grow at a CAGR of 6.4% from 2017-2027. The market is estimated at $18.33bn in 2016 and $24.19bn in 2021. In 2016, the surgical devices submarket held the largest market share at 45.9%, followed by the vision care submarket at 41.7%.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 190-page report you will receive 67 tables and 58 figures – all unavailable elsewhere.
The 190-page report provides clear detailed insight into the global ophthalmic devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Ophthalmic Devices market forecasts from 2017-2027
• This report also provides the Global Medical Devices market forecasts from 2017-2027
• This report breaks down the revenue forecast for the global ophthalmic devices market into the following submarkets: • Surgical Devices • Vision Care • Diagnostics and Monitoring
• This report breaks down the revenue forecast for the global surgical devices submarket into: • Intraocular Lenses • Ophthalmic Lasers • Ophthalmic Viscoelasatic Devices • Phacoemulsification Devices
This chapter also discussed the leading marketed products and pipeline products.
• This report breaks down the revenue forecast for the global vision care submarket into: • Daily Disposables
This chapter also discussed the leading marketed products and pipeline products.
• This report also breaks down the revenue forecast for the global ophthalmic diagnostics and monitoring submarket into: • OCT Machines • Autorefractor/Keratometer Market • Fundus Camera Market • Slit Lamp Market
This chapter also discussed the leading marketed products and pipeline products.
• This report provides individual revenue forecasts to 2027 for these national markets: • The US • Germany • France • The UK • Italy • Spain • Japan • China • Brazil • Russia • India • South Korea • Rest of the World
• Our study also discusses Porter’s Five Forces analysis that influence the global ophthalmic devices market
• Our study discusses the selected leading companies that are the major players in the ophthalmic devices industry.
Visiongain’s study is intended for anyone requiring commercial analyses for the global ophthalmic devices market. You find data, trends and predictions.
Buy our report today Global Ophthalmic Devices Market 2017-2027: Vision Care, Surgical, Diagnostics and Monitoring, Daily Disposables, Intraocular Lenses, Ophthalmic Lasers, Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Autorefractors/Keratometer, OCT Machines, Fundus Camera, Slit Lamps and Others.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Ophthalmic Devices Market Overview 1.2 Overview of Findings 1.3 Global Ophthalmic Devices Market Segmentation 1.3 Overview of Findings 1.4 Structure of the Report 1.5 Why You Should Read This Report 1.6 How This Report Delivers 1.7 Key Questions Answered by This Analytical Report 1.8 Who is This Report For? 1.9 Methodology 1.10 Frequently Asked Questions (FAQ) 1.11 Associated Visiongain Reports 1.12 About Visiongain
2. Introduction to the Ophthalmic Devices Market 2.1 The Eye: An Overview of its Structure and Function 2.2 The Global Burden of Eye Disease 2.3 Eye Diseases 2.3.1 Refractive Errors (Myopia, Hyperopia or Astigmatism) 2.3.2 Cataracts 2.3.3 Glaucoma 2.3.3.1 Diagnosis of Glaucoma 2.3.4 Age-Related Macular Degeneration (AMD) 2.3.4.1 Dry (Non-Exudative) AMD 2.3.4.2 Wet (Exudative) AMD 2.3.5 Diabetic Retinopathy (DR) 2.3.5.1 Diagnosis of Diabetic Retinopathy 2.3.6 Dry Eye Syndrome (DES) 2.4 Ophthalmic Devices: Market Segmentation 2.4.1 The Monitoring and Diagnostics Ophthalmic Devices Market 2.4.1.1 General Eye Health Monitoring Devices 2.4.1.2 Refractive Error Monitoring and Diagnostics Devices 2.4.1.3 Glaucoma Monitoring and Diagnostic Devices 2.4.2 The Surgical Ophthalmic Devices Market 2.4.2.1 Refractive Error Surgery Devices 2.4.2.1.1 LASIK Eye Surgery (Laser In-Situ Keratomileusis) 2.4.2.1.2 Photorefractive Keratectomy (PRK) 2.4.2.1.3 Phakic Intraocular Surgery 2.4.2.1.4 Conductive Keratoplasty (CK) 2.4.2.1.5 Refractive Lens Exchange (RLE) 2.4.2.1.6 Vitreoretinal Surgery Devices 2.4.2.2 Cataract Surgery Devices 2.4.2.2.1 Phacoemulsification and Intraocular Lenses 2.4.2.2.2 Microincision Cataract Surgery (MICS) 2.4.2.3 Glaucoma Surgical Devices 2.4.2.3.1 Glaucoma Lasers 2.4.2.3.2 Other Glaucoma Surgical Devices 2.4.2.4 Age-Related Macular Degeneration (AMD) Surgical Devices 2.4.2.4.1 Photodynamic Therapy 2.4.2.4.2 Laser Photocoagulation 2.4.2.4.3 Radiotherapy–Oraya Therapy 2.4.2.4.4 Newer Types of Surgery 2.4.2.5 Diabetic Retinopathy Surgery Devices 2.4.2.6 Dry Eye Syndrome Surgery Devices 2.4.2.6.1 Punctal Occlusion 2.4.2.6.2 Salivary Gland Autotransplantation 2.4.2.6.3 Tarsorrhaphy 2.4.3 The Vision Care Devices Market 2.5 Ophthalmic Devices 2.5.1 What are Ophthalmic Devices? 2.5.2 Devices: Classification 2.5.2.1 The US Medical Devices Classification System 2.5.2.2 The EU Medical Devices Classification System 2.5.2.3 The Japanese Medical Devices Classification System 2.5.3 Regulation of Ophthalmic Devices 2.5.3.1 The US Approval and Regulation System 2.5.3.2 The EU Approval and Regulation System 2.5.3.3 The Japanese Approval and Regulation System
3. The Global Ophthalmic Devices Market, 2016-2027 3.1 The Medical Devices Market Overview, 2016 3.1.1 The Global Medical Devices Market, 2017-2027 3.2 The Ophthalmic Devices Market by Submarket, 2016 3.3 The Ophthalmic Devices Market, 2017-2027
4. The Ophthalmic Surgical Devices Market, 2016-2027 4.1 The Ophthalmic Surgical Devices Market Overview 4.1.1 The Surgical Ophthalmic Devices Market, 2016 4.2 The Surgical Ophthalmic Devices Market Forecast, 2017-2027 4.2.1 The Intraocular Lenses Market Forecast, 2017-2027 4.2.1.1 Intraocular Lens Products 4.2.1.2 Intraocular Lenses Product Pipeline 4.2.1.2.1 The Light Adjustable Lens (Calhoun) 4.2.1.2.2 LiquiLens IOL (Vision Solution Technologies) 4.2.1.2.3 Smart IOL (Medennium) 4.2.1.2.4 NuLens Accommodating IOL (NuLens) 4.2.1.2.5 The FluidVision Lens (PowerVision) 4.2.2 The Ophthalmic Laser Market Forecast, 2017-2027 4.2.2.1 Refractive Lasers 4.2.2.1.1. STAR S4 IR Excimer Laser (Abbott Medical Optics) 4.2.2.1.2 iFS Advanced Femtosecond Laser (Abbott Medical Optics) 4.2.2.1.3 WaveLight Allegretto Wave Eye-Q Laser (Alcon (Novartis)) 4.2.2.1.4 WaveLight Refractive Suite (Alcon (Novartis)) 4.2.2.1.5 NIDEK Advanced Vision Excimer Laser System NAVEX Quest (Nidek) 4.2.2.1.6 TECHNOLAS TENEO 317 Laser (Bausch and Lomb (Valeant)) 4.2.2.1.7 TECHNOLAS TENEO 217P Laser (Bausch and Lomb (Valeant)) 4.2.2.2 Cataract Lasers 4.2.2.2.1 The LenSx Laser (Alcon (Novartis)) 4.2.2.2.2 LENSAR Laser System (LENSAR) 4.2.2.2.3 Catalys Precision Laser System (Abbott Medical Optics) 4.2.2.2.4 VICTUS Femtosecond Laser Platform (Bausch and Lomb Technolas) 4.2.2.2.5 Lumenis Vision (InSight) 4.2.3 The Ophthalmic Viscoelastic Devices Market, 2017-2027 4.2.4 The Phacoemulsification Devices Market Forecast, 2017-2027 4.2.5 The Other Surgical Ophthalmic Devices Market Forecast, 2017-2027 4.2.6 Ophthalmic Drug Delivery Devices 4.2.6.1 Recent Approvals 4.2.6.1.1 Retisert Fluocinolone Acetonide (Bausch and Lomb) 4.2.6.1.2 Ozurdex Dexamethasone (Allergan) 4.2.6.1.3 Iluvien Fluocinolone Acetonide (Alimera Sciences) 4.2.6.2 Novel Ocular Drug Delivery Platform Pipeline 4.2.6.2.1 ECT Platform (Neurotech Pharmaceuticals) 4.2.6.2.2 Hydrogel Technology Products (Ocular Therapeutix) 4.2.6.2.3 ProDex (Taiwan Liposome Company) 4.2.6.3 Microinvasive Glaucoma Surgery (MIGS) 4.2.6.3.1 Trabectome (NeoMedix Corporation) 4.2.6.3.2 EX-PRESS Glaucoma Filtration Devices (Alcon) 4.2.6.3.3 iStent (Glaukos) 4.2.6.4 Stents in the Glaucoma Pipeline 4.2.6.4.1 CyPass Micro-Stent (Transcend Medical) 4.2.6.4.2 Hydrus (Ivantis) 4.2.6.4.3 XEN Gel Stent (Aquesys) 4.3 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2017-2027 4.3.1 Strengths 4.3.1.1 Highest Growing Submarket 4.3.1.2 Fast Development of IOL Technology 4.3.1.3 Increasingly Sophisticated Laser Surgery 4.3.2 Weaknesses 4.3.2.1 Challenging Reimbursement Environment 4.3.3 Opportunities 4.3.3.1 Ageing Population 4.3.3.2 Rising Diabetes Epidemic 4.3.3.3 Large Pipeline of Products 4.3.4 Threats 4.3.4.1 Pharmaceuticals Compete as Therapies for Ocular Diseases
5. The Ophthalmic Vision Care Market 2016-2027 5.1 The Ophthalmic Vision Care Devices Market Overview 5.2 The Ophthalmic Vision Care Devices Market, 2017-2027 5.2.1 The Ophthalmic Vision Care Devices Market by Segment 5.2.1.1 The Ophthalmic Vision Care Devices Market by Segment, 2016 5.2.1.2 The Ophthalmic Vision Care Devices Market by Segment, 2017-2027 5.2.1.2.1 The Daily Disposable Contact Lenses Market, 2017-2027 5.2.1.2.2 The Others Contact Lenses Market, 2017-2027 5.3 Contact Lenses on the Market 5.4 The Contact Lenses Market: New Product Development and Product Pipeline 5.4.1Acuvue Oasys with HydraLuxe (Johnson & Johnson) 5.4.2 1-DAY ACUVUE MOIST Multifocal Lenses (Johnson & Johnson) 5.4.3 ULTRA with MoistureSeal (Bausch and Lomb) 5.4.4 1-DAY ACUVUE DEFINE with LACERON Technology (Johnson & Johnson) 5.4.5 Google Smart Lenses in cooperation with Novartis 5.4.6 Samsung Patents Contact Lens with a Built-In Camera 5.4.7 Sony Files Patent for Smart Contact Lenses which Can Store Data 5.4.8 Sensimed (Triggerfish) 5.5 SWOT Analysis of the Vision Care Market, 2017-2027 5.5.1 Strengths 5.5.1.1 Increasing Adoption of Disposable Contact Lenses 5.5.1.2 Contact Lenses for Non-Ocular Disorders 5.5.1.3 Linked to Changes in Consumer Spending 5.5.2 Weaknesses 5.5.2.1 High Entry Barriers for New Entry Manufacturers 5.5.2.2 Fast Downward Pricing Pressure 5.5.3 Opportunities 5.5.3.1 Growing Affluent Population in Developing Economies 5.5.3.2 Increasing Access to Diagnostic Equipment 5.5.3.3 Sales of Cosmetic and Coloured Lenses 5.5.3.3 Ageing population 5.5.4 Threats 5.5.4.1 Growing Demand for LASIK Surgery
6. The Ophthalmic Diagnostics and Monitoring Devices Market, 2016-2027 6.1 The Ophthalmic Diagnostics and Monitoring Devices Market Overview 6.2 The Ophthalmic Diagnostics and Monitoring Devices Market, 2016 6.3 The Ophthalmic Diagnostics and Monitoring Devices Market Forecast by Segment, 2017-2027 6.3.1 The OCT Machine Market Forecast, 2017-2027 6.3.1.1 Ophthalmic OCT Machine Products 6.3.2 The Autorefractor/Keratometer Market Forecast, 2017-2027 6.3.3 The Fundus Camera Market Forecast, 2017-2027 6.3.4 The Slit Lamp Market Forecast, 2017-2027 6.3.5 The Other Ophthalmic Diagnostics and Monitoring Devices Market Forecast, 2017-2027 6.4 SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market, 2017-2027 6.4.1 Strengths 6.4.1.1 Continuing Development of Improved Technologies 6.4.1.2 Stable Future Revenue through Lack of Pricing Pressure 6.4.2 Weaknesses 6.4.2.1 Shortage of Ophthalmic Device Providers 6.4.3 Opportunities 6.4.3.1 Ageing Population 6.4.3.2 Increasing Demand for Advanced Optical Coherence Tomography Machines 6.4.3.3 Increasing Demand for Advanced Ophthalmic Diagnostics 6.4.4 Threats 6.4.4.1 Increasing Cost of Healthcare
7. The Leading National Ophthalmic Devices Markets, 2016-2027 7.1 The Leading National Ophthalmic Devices Markets, 2016 7.2 The Leading National Ophthalmic Devices Markets, 2027 7.3 The Leading National Ophthalmic Devices Market Forecast, 2017-2027 7.4 The US Ophthalmic Devices Market Forecast, 2017-2027 7.5 The EU5 Ophthalmic Devices Market, 2016 7.5.1 The EU5 Ophthalmic Devices Market Forecast, 2017-2027 7.5.1.1 The German Ophthalmic Devices Market Forecast, 2017-2027 7.5.1.2 The French Ophthalmic Devices Market Forecast, 2017-2027 7.5.1.3 The UK Ophthalmic Devices Market Forecast, 2017-2027 7.5.1.4 The Italian Ophthalmic Devices Market Forecast, 2017-2027 7.5.1.5 The Spanish Ophthalmic Devices Market Forecast, 2017-2027 7.6 The Japanese Ophthalmic Devices Market Forecast, 2017-2027 7.7 The Chinese Ophthalmic Devices Market Forecast, 2017-2027 7.8 The Indian Ophthalmic Devices Market Forecast, 2017-2027 7.8 The Russian Ophthalmic Devices Market Forecast, 2017-2027 7.9 The Brazilian Ophthalmic Devices Market Forecast, 2017-2027 7.10 The South Korean Ophthalmic Devices Market Forecast, 2017-2027
8. The Leading Ophthalmic Devices Companies, 2016 8.1 Alcon (Acquired by Novartis) 8.1.1 Alcon Financial Performance, 2015-2016 8.1.2 Product Line 8.1.2.1 Surgical Division Products 8.1.2.1.1 CENTURION Vision System 8.1.2.1.2 LenSx Laser 8.1.2.1.3 WaveLight Refractive Suite 8.1.2.1.4 WaveLight Allegretto Wave Eye-Q Laser 8.1.2.1.5 ACRYSOF IOLS 8.1.2.1.6 EX-PRESS Glaucoma Filtration Device 8.1.2.1.7 INFINITI Vision System 8.1.2.2 Vision Care Products 8.1.2.2.1 AIR OPTIX 8.1.2.2.2 FOCUS DAILIES 8.1.2.2.3 FreshLook Colour Lenses 8.1.3 Mergers and Acquisitions 8.1.3.1 Novartis Acquisition of Alcon 8.1.3.2 Acquisition of Endure Medical Systems 8.1.3.3 Acquisition of SensoMotoric Instruments GmbH (SMI) – Ophthalmic Division 8.1.3.4 Acquisition of LenSx Lasers 8.1.3.5 Acquisition of WaveTec Vision 8.1.3.6 Licensing of Google [X] Smart Lens Technology 8.1.3.7 Acquistion of Transcend Medical Inc 8.2 Abbott Medical Optics (AMO) 8.2.1 AMO Financial Performance, 2014-2015 8.2.2 AMO Product Portfolio 8.2.3 Mergers and Acquisitions 8.2.3.1 Abbott’s Acquisition of Advanced Medical Optics 8.2.3.2 Acquisition of OptiMedica 8.2.3.3 Acquisition of VISX 8.3 Bausch and Lomb (B&L) (Acquired by Valeant) 8.3.1 Bausch and Lomb Financial Performance, 2015 8.3.2 Vitreoretinal Surgical Products 8.3.2.1 Retisert (fluocinolone acetonide intravitreal implant) 0.59mg. 8.3.3 Cataracts Lens Products 8.3.3.1 enVista Intraocular Lens (IOL) 8.3.3.2 TRULIGN Toric IOL 8.3.3.3 Akreos Advanced Optics (AO) and MICS Lens 8.3.3.4 Crystalens AO Lens 8.3.3.5 SofPort AO Aspheric Lens 8.3.4 Cataracts Surgery Products 8.3.4.1 Stellaris Vision Enhancement System 8.3.4.2 VICTUS Femtosecond Laser Platform 8.3.5 Mergers and Acquisitions 8.3.5.1 Acquisition of Laboratorio Pförtner Cornealent SACIF 8.3.5.2 Valeant’s Acquisition of Bausch and Lomb 8.3.5.3 Acquisition of Technolas Perfect Vision GmbH 8.3.5.4 Acquisition of Eyeonics 8.3.5.5 Bausch and Lomb’s Price Fixing in China 8.3.5.6 Bausch and Lomb Acquire Paragon Vision Care 8.3.5.7 Bausch and Lomb Continue on Speciality Lens Shopping Spree by Acquiring Alden Optical 8.4 Johnson & Johnson Vision Care 8.4.1 Johnson and Johnson Vision Care Financial Performance, 2015 8.4.1.1 Johnson and Johnson Vision Care Financial Performance, 2014-2015 8.4.2 Product Line 8.4.3 Expansion of Manufacturing Facilities 8.4.4 Fined for Price Fixing Contact Lens in China 8.5 Nidek 8.5.1 Nidek Financial Performance 8.5.2 Product Line 8.5.2.1 Surgical Systems 8.5.2.2 Intraocular Lens 8.5.2.3 Ophthalmic Lasers 8.5.2.4 Refractive Surgery Systems 8.5.2.5 Diagnostic Equipment 8.5.2.5.1 Retina and Glaucoma 8.5.2.5.2 Cornea and Cataract 8.6 Hoya Corporation 8.6.1 Hoya Financial Performance, 2015 8.6.1.1 Hoya Financial Performance by Business Segment, 2015 8.6.2 IOL Product Lines 8.7 STAAR Surgical (STAAR) 8.7.1 STAAR Surgical Financial Performance, 2012-2015 8.7.2 Product Line 8.7.2.1 Intracollamer Lenses 8.7.2.2 Intraocular Lenses 8.8 Carl Zeiss AG Meditec 8.8.1 Carl Zeiss Meditec Financial Performance, 2012-2015 8.8.1.1 Carl Zeiss Meditec Financial Performance by Business Segment, 2015 8.8.1.2 Carl Zeiss Meditec Financial Performance by Region, 2015 8.8.2 Product Line 8.8.3 Mergers and Acquisitions 8.8.3.1 Acquisition of Aaren Scientific 8.8.3.2 Cooperation Agreement with Oraya Therapeutics Inc 8.9 TopCon 8.9.1 TopCon Eye Care Company Financial Performance, 2015 8.9.1.1 TopCon Financial Performance by Business Segment, 2015 8.9.2 Product Line 8.9.2.1 3D OCT-2000 Spectral Domain OCT 8.9.2.2 Other Major Products 8.9.3 Mergers and Acquisitions 8.9.3.1 Acquisition of Optimedica’s Retina and Glaucoma Business 8.10 Haag-Streit Holding AG 8.10.1 Haag-Streit Holding AG Product Line
9. Qualitative Analysis of the Ophthalmic Devices Market, 2016-2027 9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market 9.1.1 Rivalry among Competitors [High] 9.1.2 Threat of New Entrants [Medium] 9.1.3 Power of Suppliers [Low] 9.1.4 Power of Buyers [High] 9.1.5 Threat of Substitutes [High]
10. Conclusions 10.1 The World Ophthalmic Devices Market, 2016 10.2 Leading Ophthalmic Devices Submarkets 10.3 World Ophthalmic Devices Market Forecast, 2017-2027 10.4 Leading Segments of the Ophthalmic Devices Submarkets
Visiongain’s Bespoke Research Service Some Associated Reports Visiongain Report Sales Order Form About Visiongain Report Evaluation Form
List of Tables Table 2.1 Segments and Definitions of the Ophthalmic Market Table 2.2 Global Prevalence of Visual Impairment, 2016 Table 2.3 International Classification of Disease Classification of Visual Impairment, 2016 Table 2.4 The US Classification of Medical Devices Table 2.5 The EU Classification of Medical Devices Table 2.6 The Japanese Classification of Medical Devices Table 3.1 The Global Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 3.2 Ophthalmic Devices Market Overview by Submarket: Revenue ($bn) and Market Share (%), 2016 Table 3.3 The Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.1 The Ophthalmic Surgical Devices Market by Segment: Revenue ($bn) and Market Share (%), 2016 Table 4.2 The Ophthalmic Surgical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.3 The Intraocular Lenses Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.4 Types of Premium IOLs on the Market, 2016 Table 4.5 The Ophthalmic Laser Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.6 The Ophthalmic Viscoelastic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.7 The Phacoemulsification Devices Market Forcast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.8 The Other Ophthalmic Surgical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 4.9 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2017-2027 Table 5.1 The Vision Care Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 5.2 The Ophthalmic Vision Care Devices Market by Segment: Revenue ($bn) and Market Share (%), 2016 Table 5.3 The Ophthalmic Vision Care Market Forecast by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 5.4 The Daily Disposable Contact Lenses Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 5.5 The Other Contact Lenses Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 5.6 Leading Silicone Hydrogel Contact Lenses Products in the Market, 2016 Table 5.7 SWOT Analysis of the Vision Care Devices Market , 2017-2027 Table 6.1 The Ophthalmic Diagnostics and Monitoring Market by Segment: Revenue ($bn) and Market Shares (%), 2016 Table 6.2 The Ophthalmic Diagnostics and Monitoring Market Forecast by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 6.3 The OCT Machine Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 6.4 Leading Ophthalmic OCT Machines in the Market, 2016 Table 6.5 The Autorefractor/Keratometer Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 6.6 The Fundus Camera Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 6.7 The Slit Lamp Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 6.8 The Other Ophthalmic Diagnostics and Monitoring Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 6.9 SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market , 2016-2027 Table 7.1 The Ophthalmic Devices Market by Region: Revenue ($bn), and Market Share (%), 2016 Table 7.2 The Ophthalmic Devices Market by Region: Revenue ($bn), and Market Share (%), 2027 Table 7.3 The Leading National Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.4 The US Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.5 The European Ophthalmic Devices Market by Country: Revenue ($bn) and Market Share (%), 2016 Table 7.6 The EU5 Ophthalmic Devices Market by Country Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.7 The German Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.8 The French Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.9 The UK Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.10 The Italian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.11 The Spanish Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.12 The Japanese Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.13 The Chinese Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.14 The Indian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.15 The Russian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.16 The Brazilian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 7.17 The South Korean Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027 Table 8.1 Alcon by Division: Revenue ($bn), 2014-2015 Table 8.2 Abbott Medical Optics: Product Line, 2016 Table 8.3 J&J Major Medical Devices: Revenue ($bn), Revenue Share (%) by Segment, 2015 Table 8.4 J&J Medical Devices by Segment: Revenue Share (%), 2015 Table 8.5 J&J Vision Care: Revenue ($bn), AGR (%), 2012-2015 Table 8.6 J&J Vision Care: Product Line by Wear Time, 2016 Table 8.7 J&J Vision Care: Product Line by Type of Refractive Error, 2016 Table 8.8 STAAR: Revenue ($m), AGR (%) and CAGR (%), 2012-2015 Table 8.9 STAAR: Product line Table 8.10 Carl Zeiss Meditec: Revenue ($m), AGR (%) and CAGR (%) 2012-2015 Table 8.11 Carl Zeiss Meditec by Region: Revenue Share (%), 2015 Table 8.12 Carl Zeiss Meditec: Ophthalmic Product Line Table 8.13 TopCon Eye Care Company: Revenue ($m), AGR (%) and CAGR (%), 2014-2015 Table 8.14 TopCon: Revenue ($bn), Revenue Share (%) by Division, 2015 Table 8.15 Haag-Streit: Medical Technology & Specialities
List of Figures Figure 1.1 Ophthalmic Devices: Overview of Submarkets and Devices, 2016 Figure 2.1 Structure of the Human Eye Figure 2.2 Global Prevalence of Visual Impairment, 2016 Figure 2.3 Global Share of Visual Impairment Among Different Age Groups, 2016 Figure 2.4 Global Causes of Visual Impairment (% of cases), 2014 Figure 3.1 The Global Medical Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 3.2 Ophthalmic Devices Market Overview by Segment: Revenue ($bn), 2016 Figure 3.3 Ophthalmic Devices Market Overview by Segment: Market Share (%), 2016 Figure 3.4 The Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.1 The Ophthalmic Surgical Devices Market by Segment: Revenue ($bn), 2016 Figure 4.2 The Ophthalmic Surgical Devices Market by Segment: Market Share (%), 2016 Figure 4.3 The Ophthalmic Surgical Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.4 The Intraocular Lenses Market Forcast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.5 The Ophthalmic Laser Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.6 The Ophthalmic Viscoelastic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.7 The Phacoemulsification Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 4.8 The Other Ophthalmic Surgical Devices Market: Revenue ($bn), and AGR (%), 2016-2027 Figure 4.9 Neurotech: Encapsulated Cell Technology Pipeline, 2016 Figure 4.10 Ocular Therapeutix: Punctum Plug Sustained Release Pipeline, 2016 Figure 5.1 The Vision Care Devices Market forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 5.2 The Ophthalmic Vision Care Devices Market by Segment: Revenue ($bn), 2016 Figure 5.3 The Ophthalmic Vision Care Devices Market by Segment: Market Share (%), 2016 Figure 5.4 The Ophthalmic Vision Care Market Forecast by Segment: Revenue ($bn), 2016-2027 Figure 5.5 The Daily Disposable Contact Lenses Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 5.6 The Other Contact Lenses Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 6.1 The Ophthalmic Diagnostics and Monitoring Market by Segment: Revenue ($bn), 2016 Figure 6.2 The Ophthalmic Diagnostics and Monitoring Devices Market by Segment: Market Share (%), 2016 Figure 6.3 The Ophthalmic Diagnostics and Monitoring Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 6.4 The OCT Machine Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 6.5 The Autorefractor/Keratometer Market Forecast: Revenue ($bn), and AGR (%), 2016-2027 Figure 6.6 The Fundus Camera Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 6.7 The Slit Lamp Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 6.8 The Other Ophthalmic Diagnostics and Monitoring Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.1 The Ophthalmic Devices Market by Region: Revenue ($bn), 2016 Figure 7.2 The Ophthalmic Devices Market by Region: Market Share (%), 2016 Figure 7.3 The Ophthalmic Devices Market by Region: Market Share (%), 2027 Figure 7.4 The US Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.5 The EU5 Ophthalmic Devices Market by Country: Revenue ($bn), 2016 Figure 7.6 The EU5 Ophthalmic Devices Market by Country: Market Share (%), 2016 Figure 7.7 The EU5 Ophthalmic Devices Market Forecast by Country: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.8 The German Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.9 The French Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.10 The UK Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.11 The Italian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.12 The Spanish Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.13 The Japanese Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.14 The Chinese Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.15 The Indian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.16 The Russian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.17 The Brazilian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 7.18 The South Korean Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2016-2027 Figure 8.1 Alcon by Division: Revenue Share (%), 2016 Figure 8.2 J&J Medical Devices by Segment: Revenue Share (%), 2016 Figure 8.3 Carl Zeiss Meditec by Business Unit: Revenue Share (%), 2015 Figure 8.4 Carl Zeiss Meditec by Region: Revenue Share (%), 2016 Figure 8.5 TopCon: Revenue Share (%) by Company, 2016 Figure 9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market, 2017-2027
Abbott Medical Optics, Inc. Alcon (Novartis International AG) Alimera Sciences, Inc. Allergan/Actavis PLC Aquesys, Inc. Bausch and Lomb (Valeant Pharmaceuticals International, Inc.) Calhoun Vision, Inc. Canon, Inc. Carl Zeiss Meditec AG CooperVision Essilor International S.A. Forus Health Pvt. Ltd. Genentech, Inc. Glaukos Corporation Google, Inc. Heidelberg Engineering GmbH Hoya Corporation InSight Ivantis, Inc. Johnson & Johnson LENSAR, Inc. Marco Medennium, Inc. NeoMedix Corporation Neurotech Pharmaceuticals, Inc. Nidek Co., LTD. Nikon Corporation Novartis International AG NuLens Ocular Therapeutix, Inc. Optovue, Inc. Oraya Therapeutics International, Inc. OSI Pharmaceuticals, Inc. PowerVision, Inc. Regeneron Pharmaceuticals, Inc. Seiko Epson Corporation Sensimed SA Shanghai Weicon Optics Co., LTD. STAAR Surgical Co. Taiwan Liposome Company Ltd. TopCon Corporation Tomey Corporation Transcent Medical, Inc. Vision Solution Technologies, Inc. Valeant Pharmaceuticals International, Inc. WaveTec Vision (Novartis International AG)
List of Organizations Mentioned in the Report Food and Drug Administration (US) Japanese Ministry of Health, Labour, and Welfare (MHLW) Japanese Pharmaceutical and Medical Devices Agency (PMDA) Mexican National Institute of Statistics and Geography (INEGI) US Preventive Service Task Force (USPSTF) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Global Ophthalmic Devices Market 2017-2027
Download sample pages
Complete the form below to download your free sample pages for Global Ophthalmic Devices Market 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.
Immuno-Oncology Clinical Trials market is valued at US$6,849.8 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
